BENJAMIN LONG: Open Payments
NPI 1982102885 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,610 in 77 payments from 34 companies in 2025. Trend: 2023 $1,526 · 2024 $2,320 · 2025 $2,610
Food & beverage: $2,439Education: $171
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $244 |
| Caris MPI, Inc. | 2 | $205 |
| Galvanize Therapeutics, Inc | 1 | $196 |
| Novartis Pharmaceuticals Corporation | 6 | $168 |
| AstraZeneca Pharmaceuticals LP | 5 | $163 |
| E.R. Squibb & Sons, L.L.C. | 6 | $160 |
| PFIZER INC. | 13 | $148 |
| Tempus AI, Inc | 2 | $141 |
| BeOne Medicines USA, Inc. | 1 | $125 |
| Genentech, Inc. | 1 | $118 |
Products named: RYBREVANT, MI CANCER SEEK, ALIYA SYSTEM, XT CDX, BRUKINSA, REBLOZYL, Tecentriq, OJJAARA.
Industry payments across MO — which companies pay providers there.
